Type Public Industry Pharmaceuticals Number of employees 34 | Traded as NASDAQ: CATB Website www.catabasis.com Founded 2008 | |
Key people Jill C. Milne, Ph.D. (CEO) Joanne M. Donovan, M.D., Ph.D. (Chief Medical Officer and Senior Vice President, Clinical Development) Ted Hibben (Chief Business Officer)
Andrew Nichols, Ph.D. (Chief Scientific Officer) Products Orally-delivered pharmaceuticals Stock price CATB (NASDAQ) US$ 1.13 -0.04 (-3.42%)3 Mar, 4:00 PM GMT-5 - Disclaimer Headquarters Massachusetts, United States | ||
Catabasis Pharmaceuticals, founded in 2008 and based in Cambridge, Mass., is a clinical-stage biopharmaceutical company. Catabasis’ SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables the company to engineer molecules that simultaneously modulate multiple targets in a disease. Catabasis is applying their SMART linker platform to build an internal pipeline of product candidates for rare diseases and plans to pursue partnerships to develop additional product candidates.
Catabasis pharmaceuticals top 5 facts
References
Catabasis Pharmaceuticals Wikipedia(Text) CC BY-SA